Unanticipated Mycobacterium tuberculosis complex culture inhibition by immune modulators, immune suppressants, a growth enhancer, and vitamins A and D: clinical implications-Reference-Cited by-同舟云学术

Unanticipated Mycobacterium tuberculosis complex culture inhibition by immune modulators, immune suppressants, a growth enhancer, and vitamins A and D: clinical implications

Published:2014-09 Issue: Volume:26 Page:37-43
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Greenstein Robert J.,Su Liya,Shahidi Azra,Brown William D.,Clifford Anya,Brown Sheldon T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference82 articles.

1. World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?;Dooley;J Infect Dis,2013

2. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa;Klopper;Emerg Infect Dis,2013

3. Tuberculosis, drug resistance, and the history of modern medicine;Keshavjee;N Engl J Med,2012

4. WHO Group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis;Chang;Antimicrob Agents Chemother,2013

5. A comprehensive regulatory framework to address the unmet need for new antibacterial treatments;Rex;Lancet Infect Dis,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The antimicrobial activity of innate host-directed therapies: A systematic review;International Journal of Antimicrobial Agents;2024-05

2. Vitamin A: a key coordinator of host-microbe interactions in the intestine;BMB Reports;2023-02-14

3. Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research;Nutrients;2022-11-26

4. All trans retinoic acid as a host-directed immunotherapy for tuberculosis;Current Research in Immunology;2022

5. Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis;Antimicrobial Agents and Chemotherapy;2021-06-17